Register
Login:
Share:
Email Facebook Twitter

Add Lidco to quick picks

Lidco Share Price (LID)



Share Price Information for Lidco (LID)


Share Price: 15.125Bid: 14.75Ask: 15.50Change: 0.00 (0.00%)No Movement on Lidco Grp
Spread: 0.75Spread as %: 5.08%Open: 15.125High: 15.125Low: 15.125Yesterday’s Close: 15.125
InfoGet Live Streaming Prices for LID - Click here to start your 30 day FREE trial today.


Lidco Group Plc Ord 0.5P

Lidco is listed in the FTSE AIM All-Share
Lidco is part of the Health Care Equipment & Services sector




Intraday Lidco Share Chart




Share Price SpacerPrice
15.125

Share Price SpacerBid
14.75

Share Price SpacerAsk
15.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
0

Share Price SpacerOpen
15.125

Share Price SpacerHigh
15.125

Share Price SpacerLow
15.125

Share Price SpacerClose
15.125

Share Price SpacerCurrency
GBX

3 Month Lidco Share Graph




Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 194.18m £29.37m 5,000

52 Week High 28.88 52 Week High Date 27-JAN-2014
52 Week Low 13.25 52 Week Low Date 18-AUG-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 100.833 0.15 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

26-Aug-14
13:49:53
14.7538
900
Sell* 
14.75
15.50
132.78
Trade Type:
Ordinary

26-Aug-14
10:02:56
14.7538
431
Sell* 
14.75
15.50
63.59
Trade Type:
Ordinary

26-Aug-14
08:00:44
14.7538
1,537
Sell* 
14.75
15.50
226.77
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Lidco trades >>

Directors Deals for Lidco (LID)
Trade DateActionNotifierPriceCurrencyAmountHolding
13-Nov-12Placing
Trade Notifier Information for LiDCO Group
Paul Leighton Clifford held the position of Group Finance Director at LiDCO Group at the time of this trade.
 Paul Leighton Clifford
13.5GBX59,660659660
20-Jul-11Sell
Trade Notifier Information for LiDCO Group
John Barry held the position of Sales & Marketing Director at LiDCO Group at the time of this trade.
 John Barry
17GBX60,753475139
14-Jul-11Exercise of option
Trade Notifier Information for LiDCO Group
John Barry held the position of Sales & Marketing Director at LiDCO Group at the time of this trade.
 John Barry
0.5GBX106,250535892
View more Lidco directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
29 Apr '14
shan
LID
23.25
No Opinion

maiden profit
10 Apr '14
shan
lid
24.50
No Opinion

from what I know, the lidco system is recommended for all high risk surgery...but will find out more when I go hospital next. btw...up today as recommended by Faraday
29 Mar '14
Shipmate1
nice
23.25
No Opinion

to see a quick recovery i guess A.and E will be busy with lots of sticky plasters for the bears caught short
15 Mar '14
gasman007
Cardiac output monitoring
21.00
No Opinion

Please note - my comments are not directed at LiDCO alone, but at all companies that claim their technology improves outcomes from major surgery by measuring/monitoring cardiac output. I have no direct links to any of these companies, and neither do I engage in any social activities (unlike many of the researchers who publish studies with these companies that fund their trials and research departments). The next generation of devices may be better at delineating individual physiological changes but at present I don't think we are there yet and the research data confirms this.
15 Mar '14
gasman007
Response
21.00
No Opinion

I'm not suggesting you must choose; my point is the evidence does NOT YET PROVE that cardiac output monitoring improves outcome. If it was so amazing and had such potential to improve morbidity and mortality, then why does the data need to be played with in order to demonstrate efficacy. Probably because in a very small, selective, sub-group of patients this technology might possibly improve care but it is unlikely to make a difference in many patients especially those who are otherwise fit but undergoing major surgery. The inherent bias in all of these studies is the way in which this monitoring forces clinicians to focus more on individual patient care - it isn't necessarily the technology per se making the improvements, but rather the additional time/effort spent looking at the patient because of a protocol. Feel free to invest in this, but I still don't believe human physiology can be pinned to a series of algorithms based on assumptions and sometimes even cadaveric data, especially when you have complex elderly patients undergoing major surgery. This technology is easier to standardise using fit and healthy middle aged subjects to derive such algorithms and I don't believe they are as reliable in medically unwell patients which is principally why we have to play with the data or make so many excuses as to why the data lacks statistical significance let alone clinical significance.
14 Mar '14
DIRTYDOG
gasman007
21.00
No Opinion

you would still have an anaesthetist or intensive care doctor with 20 years of experience proving/assisting with treatment - this technology is not instead of that. its just a way of improving the outcome of treatment further.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Lidco (LID) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Lidco Group Plc Ord 0.5P home pageWebsite: Lidco Group Plc Ord 0.5P
Website Description: LiDCO Cardiac Sensor Systems for measuring Cardiac Output



Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.